MATERNAL SERUM SCREEN 4; QUADRUPLE TEST
MRP - ₹ 3,630
What is a MATERNAL SERUM SCREEN 4; QUADRUPLE TEST?
Maternal Serum Screen 4, also called the Quadruple Test, is a blood test done during pregnancy to check levels of four substances in the mother’s blood. It is needed to assess the baby’s risk of certain chromosomal conditions such as Down syndrome and Trisomy 18, as well as neural tube defects like spina bifida, so that further evaluation can be planned if required.
Additional Information
| Also known as/ Other names: | Quadruple Marker Test, Quad Screen Test, Maternal Quadruple Screening, Prenatal Quad Marker Test |
| Parameters: | 1 |
| Recommended for: | Female |
| Sample Type: | Blood |
| Patient Preparation: | Acceptable between 14 to 22 weeks + 6 days gestation. USG is mandatory must include BPD & referring doctor. |
| Reports: | Same Day |
FAQs
It is generally performed in the second trimester, usually between 15 and 22 weeks of pregnancy.
No, it only estimates risk. It cannot confirm whether the baby has a genetic condition.
The test measures AFP, hCG, unconjugated estriol, and inhibin A.
It helps assess the risk of Down syndrome, Trisomy 18, and open neural tube defects.
A high-risk result means the chance of a chromosomal or birth defect may be higher, and further testing may be advised.
A low-risk result means the chance of the condition is lower, but it does not guarantee a completely normal pregnancy.